We conducted a study to determine if a five-item pediatric cough questionnaire (PCQ) is a valid and reliable means of measuring cough-specific quality of life in children. The five questions, which are answered by the child'sparent or caregiver, cover cough frequency (Q1), sleep disturbance of the child (Q2), sleep disturbance of the parent (Q3), cough severit y (Q4), and the degree of bothersomeness to the child (Q5). Each of thefive items was scored on a 6-point Likert scale. The PCQ was administered three times. The first occurred when the parent telephoned to schedule an appointment for the child at a pediatric pulmonology outpatient clinic for a chief complaint of cough. The second PCQ was administered within 2 weeks of thefirst but before any treatment had been instituted so that test-retest reliability could be assessed. Each child was then diagnosed and treated in accordance with standardcare practices. The third PCQ was administered 3 weeks after the second to determine if it would accurately reflect the parent's perception of how the child's cough had changed following treatment. Also, at the second and third encounters, parents were askedtoprovide theirglobal assessment of whether their child's cough had improved, worsened, orstayedthesame since the previous encounter. Theparents of 120 children (70 boys and 50 girls; mean age: 6.8 yr) completed all three PCQs. Test-retest reliability was established (p < 0.001)for each of the five PCQ questions by Spearman correlation analysis (Ql: r =0.5; Q2: r =0.38; Q3: r = 0.42; Q4: r =0.53; Q5: r =0.5).Otherstatistical analyses confirmed the PCQ's internal consistency, discriminant validity, and convergent validity. Basedon ourfindings, we conclude that the PCQ is a valid and reliable instrument with which to follow children with chronic cough longitudinally.
Introduction
Cough is both an important physiologic component of lung defense and a cardinal indicator of disease. In the United States, cough remains the most common reason that patients seek medical attention, and it is the second most common reason for medical visits by children.I. 2 The estimated prevalence of cough in children is 5 to 15%,102 Overall, chronic cough has been reported to account for 10 to 38% of visits to pulmonologists' outpatient practices.r "
The metamorphosis of coughing from a normal to a pathologic event can be measured in terms of frequency, character, and duration.v' Each of these characteristics, along with a child's age, informs our decisions about diagnosis and management. For children with chronic cough, defined as cough that lasts for more than 3 weeks,' the differential diagnosis is broad; it includes self-limited, persistent, and chronic diseases. An isolated cough in an otherwise healthy child may arise secondary to recurrent viral bronchiolitis, a postinfection etiology, pertussis, cough variant asthma, or postnasal drip, or it may be psychogenic. Possible significant underlying causes of cough include cystic fibrosis, primary ciliary dyskinesia, immune deficiencies, chronic bronchitis, a retained foreign body, airway lesions, tracheomalacia, extrinsic compression of the airway, and interstitial lung disease. "
.Healthy children experience an average of 10 episodes ofcough per 24 hours."Acute respiratory infections can occur in healthy children between 5 and 8 times per year. With each episode, a child may cough for more than a www.entjournal.com • 1213
week.In agivenyear,this could translate to approximately 50 days of cough.'? Even when cough is self-limi ted, as it is in mos t cases, it can still be disruptive to both childre n and their parents if it leads to physical and/or psychological morbidity," Coug h can interfere with the daily activities and sleep of children and their parents, and its effects can be measured in terms of days missed from schoo l and lost from work.
The impact of cough can also. be meas ure d in eco-· no mic terms, and th at impact is quite large. Consumers spend billion s of dollars per year on over-the-coun ter medications for cough." :" The an nual aggregate cost of treatin g cou gh in th e United States in th e 1980s exceeded $1 billion. " Altho ugh more recent estimates are not available, thi s figur e certainly underestimates costs today. In the Un ited Kingdom, where th e prevalence of tro ublesome cough is 20%, pat ients cons ume 75 million doses of over-the-counter antitussive medications annually.IS Despite the great socioeconomic burden of chronic cough, there is a paucity of objective and well-validated measures of quality-of-life outcomes. " In 2004, Paul et al pub lished a five-item pediatric cough quest ionnaire (PCQ) to assess cou gh-specific quality-of-life issues for childre n and their parents ." Until now, the PCQ has not been formally valida ted, altho ugh the stu dy by Paul et al did demo nstrate some aspects of discriminant validity: We conducted a study to determ ine th e validity and reliability of our slightly mod ified version of the PCQ that was develop ed by Paul et al."
Subjects and methods
The goal of our study was to test the psychometri c
The five-item pediatric cough questionnaire* properties of the PCQ in the parents of children with chronic cough in the greater Boston area. Thus, we administered the PCQ to the parents of children who presented to the pediatric pulmonology office at the Massachusetts General Hosp ital for Children or at one of its suburban satellite offices for an evaluatio n of chronic cough . In addit ion to the ques tionnaire itself, we obtained demog rap hic information an d inform ation on underlying causes. Because the PCQ has no t been tra nslated int o Spanish, we focused on English-speaking pare nts, including th ose whose English was lim ited but who were still able to read and understand the PCQ.
The answers to th e five question s were scored on .a 6-point Likert scale from 0 th rou gh 5, an d possible overall scores ranged from 0 to 25; lower scores ind icated a poorer cough-related qu ality of life (see "T he five-item pedia tric cough qu estionnaire"). Our versio n of the PCQ differed slightly from that first pu blished by Paul et al," which was based on a 7-point Likert scale. We deleted one of th eir possible answers ("a lot") because we felt it is syno nymous with another of their possible answers ("very much"). We also made some mi nor grammatical changes.
The PCQ wasadministered three times.The first survey was conducted when a pare nt telephoned to make the ini tial office appoi ntment for his or her child; this was designa ted tim e point 1 (TPI). The appointment was then scheduled for within 2 weeks of the pho ne call.Th e second survey was conducted at the office visit before any treatment had been instituted (TP2); th e purpose of th e second survey was to gauge test-retest reliability. Th e child was th en evaluated and treate d according to standard care practices. The third survey was conducted 01. How frequent was your child's cough last night? • Values greater than 0.8 are assumed to reflect internal instrument CO /lsistency.
• ValuesfornonparametricdiscretecategoriesbetweellTPI alldTP2forthose parents who reportedthat the cough status of theirchild had not changed. 
Results
We administered the PCQ to the parents of 120 children -70 boys and 50 girls aged 1 to 18 years (mean: Validity. Discriminant validity was established in that the mean PCQ score at TP3 (post-treatment) was significantly different from the mean score at TP1 (pretreatment) in cases in which parents reported that
The Spearman correlation for test-test reliability is used when an instrument isadministered to a population at two distinct times that are separated by a relatively short interval during which no intervention is given."
The assumption is that a patient's health status will be the same at the two distinct times, and therefore there sho uld be a rob ust corre lation between the findings of both tests-or in other words , no statistically significant difference between them.
The Cronbach alpha test is used to determine an instrument's reliability when one item is deleted from the calculations. A finding that the Cronbach alpha value for the remaining items increases significantly after an item is deleted suggests that the deleted item may be less relevant than other items. " Values greater than 0.8 are assumed to reflect instrumerit consistency.
Validity measures. We measured both discr iminant validity and convergence validity. The hypothesis with respect to the discriminant validity of the PCQ is that there sho uld be a significant difference between mean TP 1and TP3 scores for children whose cough had either improved or worse ned after treatment according to the parent's global assessment. For convergent validity, the hypothesis is that there should not be a significant difference in the mean scores between TP1 and TP3 scores for children whose cough was unchanged after treatment accord ing to the parents.
Sample-size calculations.We calculated that a sample size of 104 children would be necessary to achieve 80% power (when p is set at 0.05) in demonstrating a mean change of 3 points in overall PCQ scores. Therefore, we selected a goal of 120 children as the size of our study population in order to be ' well above the calculated number. the ir child's cough had either improved (Wilcoxon signed rank test: p < 0.001) or worsened (p = 0.003) .
Conve rgent validity was established in that the m ean PCQ score at TP3 was not significantly different from the TP1 score in cases in which parents reported that th eir child 's cough was unchanged after treatment (p = 0.19) (table 3) .
Discussion
Our review of th e literature on chronic cough in adults and in children revealed the many difficulties associated with attempting to mea sure its prevalence and its impact on health-related qualityoflife. Some authors have used "cough meters" to count the number of coughs over a given period Oftime. 19, 20 Others have used various questionnaires to evaluate different aspects of cough, wheezing, and other respiratory symptoms." :" Several cough-specific quality-of-life questionnaires have been developed, but they were designed to evaluate cough in adults rather than children. 11 ,22,23 In our study, we validated our slightly modified version of the PCQ developed by Paul et al." Taken at face value, this PCQ is an intuitively straightforward and comprehensive instrument. However, in order for any such instrument to be considered scientifically valid , it must be shown to actually measure what it purports to measure (validity), and it must do so con sistently (reliability) .Furthermore,the instrument must demonstrate adequate psychometric properties, and it must include a me aningful scoring metric. Finally, it sho uld not be onerous to administer or to complete. Our sample size was sufficiently larg e to demonstrate statistical significance. Our findings confi rm that a 3-point difference in PCQ score is clinically significant.
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We established discriminant validity by proving the hypothesis that there should be a significant difference between m ean PCQ scores at TP1 and TP3 in children whose cough had either improved (p < 0.001) or worsened (p = 0.003) . Convergent validity was established by proving the hypothesis that th ere should not be a significant difference in these scores when the child 's cough was unchanged (p = 0.19). We also found that the PCQ demonstrated excellent reliability, that it is stra ightforward and easy to administer, and that it was readily accepted by study participants, as evidenced by the 100% retention rate throughout the duration of the study.
It is possible that our findings were bia sed as a result of the study population we selected; since thePCQ has not been translated, we enrolled only English-speaking subjects. Another possible limitation ofour study is that we did not take into account either physical findings or objective measures of cough, and we did not make our own global assessment ofany child 's cough status; instead we relied solely on responses to the questionnaire.
Although further validation studies would be helpful, our findings represent an important first step in the development of valid and reliable methods (where none currentlyexists ) ofmeasuring the impact of related treatments, such as therapy for occult gastroesophageal reflux in children with chronic cough. Also, further studies comparing PCQ responses with peak flow or spirometry results would be of interest. likely than other forms to violate the middle ear cavity, and the y commonly require surgical treatment." The choic e of procedure is dete rmined by the extent of the cholesteatoma and the surgeon's judgment. Canaloplasty is sufficient for small lesions th at do not involve the mastoid air cell.Skin grafting is beneficial when there is a large defect. For patients with asm allposterior walldefect that doe s not involve the middle ear cavity, can al-wallup mastoidectomy and canal wall recon struction can be used. For patients who have a large posterior wall defect . and involvem ent of the middle ear cavity, canal-walldown mastoidectomy is recommended. 4 Cholesteatoma excision must be accompanied by canaloplasty when a bony or cartilaginous can al sten osis is believed to be the cause of the cholesteatoma."
